Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/4/25 17:35 | 4/2/25 | BCYC | Health | Drug | Pharmaceutical Preparations | Young Alethia | X0 | O | CFO | 1 | S | -2 | 8.02 | 0 | 0 | 0 | 45 | D | ||||||||||||||
4/4/25 17:35 | 4/2/25 | BCYC | Health | Drug | Pharmaceutical Preparations | Skynner Michael | X0 | O | CTO | 1 | S.m | -14 | 7.72 | 0 | -2 | 122 | D | |||||||||||||||
4/4/25 17:35 | 4/2/25 | BCYC | Health | Drug | Pharmaceutical Preparations | Lee Kevin | X0 | DO | CEO | 1 | S.m | -44 | 7.69 | 0 | -6 | 486 | D | |||||||||||||||
4/4/25 17:35 | 4/2/25 | BCYC | Health | Drug | Pharmaceutical Preparations | Milnes Alistair | X0 | O | COO | 1 | S.m | -17 | 7.76 | 0 | -2 | 98 | D | |||||||||||||||
4/4/25 17:35 | 4/2/25 | BCYC | Health | Drug | Pharmaceutical Preparations | Hannay Michael Charles Ferguson | X0 | O | CHIEF PR | 1 | S.m | -6 | 7.82 | 0 | -1 | 55 | D | |||||||||||||||
4/4/25 17:35 | 4/2/25 | BCYC | Health | Drug | Pharmaceutical Preparations | Thompson Travis Alvin | X0 | O | Chief Ac | 1 | S.m | -3 | 7.84 | 0 | 0 | 32 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |